The panelists discuss guidelines for diagnostic test use and the biggest challenge from a payer standpoint.
Francisco J. Esteva, MD, PhD, and Daniel F. Hayes, MD, discuss guidelines for diagnostic test use from the National Comprehensive Cancer Network and the American Society of Clinical Oncology and the differences in how each organization approached the development of guidelines.
John L. Fox, MD, added that the biggest challenges with guidelines are the underuse and overuse of diagnostics—the former being a larger issue than the latter. From a payer vantage, tests that are well validated and have clinical utility should be done and they are willing to pay because the high cost of patients receiving an inappropriate therapy is an avoidable expense.
“So we’re encouraging testing and making sure that patients are appropriate for therapy,” he said.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More